An interventional study of TECAR therapy and conventional physiotherapy in Supraspinatus Tendonitis, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Is the TECAR therapy effective on supraspinatus tendon thickness, sub acromial space, pain intensity , shoulder range of motion, muscle strength ( supraspinatus and middle fiber of deltoid) and functional disabilities in patients with supraspinatus tendinitis?
Supraspinatus tendinitis is a common disorder of the rotator cuff characterized by inflammation and degeneration of the supraspinatus tendon, typically resulting from repetitive overhead activities, mechanical impingement beneath the acromion, or age-related degenerative changes. This condition often leads to shoulder pain, reduced range of motion, and functional impairment during arm elevation and overhead movements. Recently, Studies demonstrated that the addition of TECAR therapy to a standard physiotherapy regimen improves shoulder pain, disability, and passive range of motion in patients with adhesive capsulitis, supporting the use of TECAR as an effective modality in shoulder musculoskeletal rehabilitation.
397 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.
This study's planned enrollment of 50 is close to the median of 48 across 332 interventional studies indexed under Tendinopathy.
Browse Tendinopathy studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
25 Patients will receive TECAR therapy and conventional physiotherapy three times per week for four weeks
Other: TECAR therapy · Other: conventional physiotherapy
25 patients will receive conventional physiotherapy only three times per week for four weeks
Other: conventional physiotherapy
Patients will be in a comfortable side-lying with treated shoulder uppermost and clean the area over the affected shoulder, apply coupling medium and then apply Capacitive mode to shoulder muscles for 10 minutes and Resistive mode for another 10 minutes.
Patients will receive conventional physiotherapy (range of motion exercises, stretching exercises, strengthening exercises, and scapular stabilization exercises).
tendon thickness of supraspinatus muscle
tendon thickness of supraspinatus muscle will be measured by ultrasonography
Time frame: up to four weeks
Sub acromial space
Sub acromial space will be assessed using Ultrasonography.
Time frame: up to four weeks
pain intensity
visual analogue scale (VAS) will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 10 cm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel (10).
Time frame: up to four weeks
Shoulder Range of motion
Shoulder range of motion will be assessed using an electro goniometer.
Time frame: up to four weeks
Muscle strength
Muscle strength will be assessed using a handheld dynamometer (Lafayette Manual Muscle Tester).
Time frame: up to four weeks
Shoulder functional disability
Shoulder functional disability will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH). Quick DASH questionnaire is an 11-item patient-reported outcome measure designed to evaluate physical function and symptoms in individuals with upper extremity disorders. Each item is scored on a 5-point Likert scale ranging from "no difficulty" to "unable," and the total score is calculated by transforming the mean of the responses into a 0-100 scale, where higher scores indicate greater disability.
Time frame: up to four weeks
Plan to share: Yes — we will share the results of the trial 1-Supraspinatus tendon thickness 2-Subacromial space 3-Pain intensity 4-Shoulder range of motion 5-Muscle strength 6-Shoulder functional disability
Supporting information: Study protocol
Time frame: one year
Access criteria: the criteria will be accessed by the publication of trials in international journal
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.